Perspective: Therapeutic Potential of Flavonoids as Alternative Medicines in Epilepsy

Jae Young Kwon; Min-Tae Jeon; Un Ju Jung; Dong Woon Kim; Gyeong Joon Moon; Sang Ryong Kim

doi:10.1093/advances/nmz047

journal article Open Access Sep 01, 2019

Perspective: Therapeutic Potential of Flavonoids as Alternative Medicines in Epilepsy

Jae Young Kwon

Min-Tae Jeon Un Ju Jung Dong Woon Kim

Gyeong Joon Moon

Sang Ryong Kim

Advances in Nutrition Vol. 10 No. 5 pp. 778-790 · Elsevier BV

View at Publisher Save 10.1093/advances/nmz047

Topics

No keywords indexed for this article. Browse by subject →

References

136

[1]

WHO (2005)

[2]

Singh "The epidemiology of global epilepsy" Neurol Clin (2016) 10.1016/j.ncl.2016.06.015

[3]

Zack "National and state estimates of the numbers of adults and children with active epilepsy—United States, 2015" MMWR Morb Mortal Wkly Rep (2017) 10.15585/mmwr.mm6631a1

[4]

ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology

Ingrid E. Scheffer, Samuel Berkovic, Giuseppe Capovilla et al.

Epilepsia 2017 10.1111/epi.13709

[5]

Hermann "Cognitive prognosis in chronic temporal lobe epilepsy" Ann Neurol (2006) 10.1002/ana.20872

[6]

Keary "Multivariate neuropsychological prediction of seizure lateralization in temporal epilepsy surgical cases" Epilepsia (2007) 10.1111/j.1528-1167.2007.01098.x

[7]

Holmes "Cognitive impairment in epilepsy: the role of network abnormalities" Epileptic Disord (2015) 10.1684/epd.2015.0739

[8]

French "New generation antiepileptic drugs: what do they offer in terms of improved tolerability and safety?" Ther Adv Drug Saf (2011) 10.1177/2042098611411127

[9]

Early Identification of Refractory Epilepsy

Patrick Kwan, Martin J. Brodie

New England Journal of Medicine 2000 10.1056/nejm200002033420503

[10]

Sorensen "Novel approaches to epilepsy treatment" Epilepsia (2013) 10.1111/epi.12000

[11]

Matsuo "Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures: U.S. Lamotrigine Protocol 0.5 Clinical Trial Group" Neurology (1993) 10.1212/wnl.43.11.2284

[12]

Messenheimer "Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, cross-over trial" Epilepsia (1994) 10.1111/j.1528-1157.1994.tb02920.x

[13]

French "A systematic review of the safety profile of levetiracetam: a new antiepileptic drug" Epilepsy Res (2001) 10.1016/s0920-1211(01)00296-0

[14]

Bauer "Seizure-inducing effects of antiepileptic drugs: a review" Acta Neurol Scand (1996) 10.1111/j.1600-0404.1996.tb00047.x

[15]

Middleton "The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer" Pharmacol Rev (2000)

[16]

Jeong "Naringin attenuates autophagic stress and neuroinflammation in kainic acid-treated hippocampus in vivo" Evid Based Complement Alternat Med (2015) 10.1155/2015/354326

[17]

Jang "Naringin attenuates granule cell dispersion in the dentate gyrus in a mouse model of temporal lobe epilepsy" Epilepsy Res (2016) 10.1016/j.eplepsyres.2016.03.001

[18]

Park "Naringenin ameliorates kainic acid-induced morphological alterations in the dentate gyrus in a mouse model of temporal lobe epilepsy" Neuroreport (2016) 10.1097/wnr.0000000000000678

[19]

Jeong "Effects of eugenol on granule cell dispersion in a mouse model of temporal lobe epilepsy" Epilepsy Res (2015) 10.1016/j.eplepsyres.2015.06.001

[20]

Kim "Beneficial effects of silibinin against kainic acid-induced neurotoxicity in the hippocampus in vivo" Exp Neurobiol (2017) 10.5607/en.2017.26.5.266

[21]

Lee "Morin prevents granule cell dispersion and neurotoxicity via suppression of mTORC1 in a kainic acid-induced seizure model" Exp Neurobiol (2018) 10.5607/en.2018.27.3.226

[22]

Kwon "Beneficial effects of hesperetin in a mouse model of temporal lobe epilepsy" J Med Food (2018) 10.1089/jmf.2018.4183

[23]

Houser "Granule cell dispersion in the dentate gyrus of humans with temporal lobe epilepsy" Brain Res (1990) 10.1016/0006-8993(90)91601-c

[24]

Armstrong "The neuropathology of temporal lobe epilepsy" J Neuropathol Exp Neurol (1993) 10.1097/00005072-199309000-00001

[25]

Lurton "Possible mechanisms inducing granule cell dispersion in humans with temporal lobe epilepsy" Epilepsy Res (1997) 10.1016/s0920-1211(96)01002-9

[26]

Harding "Bilateral hippocampal granule cell dispersion: autopsy study of 3 infants" Neuropathol Appl Neurobiol (2001) 10.1046/j.0305-1846.2001.00325.x

[27]

Haas "Role for reelin in the development of granule cell dispersion in temporal lobe epilepsy" J Neurosci (2002) 10.1523/jneurosci.22-14-05797.2002

[28]

Heinrich "Reelin deficiency and displacement of mature neurons, but not neurogenesis, underlie the formation of granule cell dispersion in the epileptic hippocampus" J Neurosci (2006) 10.1523/jneurosci.5516-05.2006

[29]

Tinnes "Epileptiform activity interferes with proteolytic processing of Reelin required for dentate granule cell positioning" FASEB J (2011) 10.1096/fj.10-168294

[30]

Orcinha "Seizure-induced motility of differentiated dentate granule cells is prevented by the central Reelin fragment" Front Cell Neurosci (2016) 10.3389/fncel.2016.00183

[31]

Frotscher "Epilepsy-associated Reelin Dysfunction Induces Granule Cell Dispersion in the Dentate Gyrus" (2017)

[32]

Zeng "The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy" J Neurosci (2009) 10.1523/jneurosci.0066-09.2009

[33]

Shima "Activation of mTOR signaling pathway is secondary to neuronal excitability in a mouse model of mesio-temporal lobe epilepsy" Eur J Neurosci (2015) 10.1111/ejn.12835

[34]

Kim "Control of granule cell dispersion by natural materials such as eugenol and naringin: a potential therapeutic strategy against temporal lobe epilepsy" J Med Food (2016) 10.1089/jmf.2016.3712

[35]

McNamara "Emerging insights into the genesis of epilepsy" Nature (1999) 10.1038/399a015

[36]

Bialer "Key factors in the discovery and development of new antiepileptic drugs" Nat Rev Drug Discov (2010) 10.1038/nrd2997

[37]

White "Mechanisms of action of antiepileptic drugs" Int Rev Neurobiol (2007) 10.1016/s0074-7742(06)81006-8

[38]

Liu "The mechanism of carbamazepine aggravation of absence seizures" J Pharmacol Exp Ther (2006) 10.1124/jpet.106.104968

[39]

Tateno "Carbamazepine-induced transient auditory pitch-perception deficit" Pediatr Neurol (2006) 10.1016/j.pediatrneurol.2006.01.011

[40]

Shorvon "Drug treatment of epilepsy in the century of the ILAE: the second 50 years, 1959–2009" Epilepsia (2009) 10.1111/j.1528-1167.2009.02042.x

[41]

Jentink "Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case–control study" BMJ (2010) 10.1136/bmj.c6581

[42]

Perucca "Adverse effects of antiepileptic drugs" Lancet Neurol (2012) 10.1016/s1474-4422(12)70153-9

[43]

Nevitt "Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review" Cochrane Database Syst Rev (2018)

[44]

Sharafuddin "Phenytoin-induced agranulocytosis: a nonimmunologic idiosyncratic reaction?" Acta Haematol (1991) 10.1159/000204838

[45]

Scheinfeld "Phenytoin in cutaneous medicine: its uses, mechanisms and side effects" Dermatol Online J (2003) 10.5070/d32197w4t4

[46]

Rogawski "The neurobiology of antiepileptic drugs" Nat Rev Neurosci (2004) 10.1038/nrn1430

[47]

Handoko "Risk of aplastic anemia in patients using antiepileptic drugs" Epilepsia (2006) 10.1111/j.1528-1167.2006.00596.x

[48]

Rogawski "Diverse mechanisms of antiepileptic drugs in the development pipeline" Epilepsy Res (2006) 10.1016/j.eplepsyres.2006.02.004

[49]

Faught "Topiramate in the treatment of partial and generalized epilepsy" Neuropsychiatr Dis Treat (2007)

[50]

St Louis "Minimizing AED adverse effects: improving quality of life in the interictal state in epilepsy care" Curr Neuropharmacol (2009) 10.2174/157015909788848857

Showing 50 of 136 references

Metrics

39

Citations

136

References

Details

Published: Sep 01, 2019
Vol/Issue: 10(5)
Pages: 778-790
License: View

Authors

Funding

National Research Foundation of Korea Award: NRF-2017R1A2B4002675

Cite This Article

Jae Young Kwon, Min-Tae Jeon, Un Ju Jung, et al. (2019). Perspective: Therapeutic Potential of Flavonoids as Alternative Medicines in Epilepsy. Advances in Nutrition, 10(5), 778-790. https://doi.org/10.1093/advances/nmz047

Perspective: Therapeutic Potential of Flavonoids as Alternative Medicines in Epilepsy

You May Also Like